-
Damm K., de Jong L., Lückemann M., Herr A.
(2022):
Der CCI-6D: Indexinstrument zur Messung der Pflegeheimqualität [The CCI-6D: index instrument for measuring nursing home quality],
Public Health Forum 30(3):190-192.
-
de Jong L., Stahmeyer J.T., Eberhard S., Zeidler J., Damm K.
(2022):
Willingness to provide informal care to older adults in Germany - a discrete choice experiment,
European Journal of Health Economics
Weitere Informationen
-
de Jong L., Zeidler J., Damm K.
(2022):
A systematic review to identify the use of stated preference research in the field of older adult care,
European Journal of Ageing,19:1005-1056.
-
Damm K., Lingner H, Schmidt K., Aumann-Suslin I., Buhr-Schinner H., van der Meyden, J., Schultz K.
(2021):
Preferences of patients with asthma or COPD for treatments in pulmonary rehabilitation,
Health Economics Review,11(1),1-12
-
de Jong L., Stahmeyer J.T., Eberhard S., Zeidler J., Damm K.
(2021):
Willingness and preparedness to provide care: interviews with individuals of different ages and with different caregiving experiences,
BMC Geriatrics, 21:207
-
Herbst F.A., Stiel S., Damm K., de Jong L., Stahmeyer J.T., Schneider N.
(2021):
Exploring the status of and demand for palliative day-care clinics and day hospices in Germany: a protocol for a mixed- methods study,
BMC Palliative Care,20(1):1-9
-
de Jong L., Stahmeyer J.T., Eberhard S., Zeidler J., Damm K.
(2020):
„Aber vielfach scheitert man dann an Besonderheiten“ – Pflegeberater über Gesetzesänderungen und die Herausforderungen ihrer Arbeit: Eine qualitative Untersuchung ["But you often come unstuck on particularities" - Care consultants on legislation amendments and the challenges of their job: A qualitative investigation],
Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, 150-152:65-72
-
Babac A., Damm K., Graf von der Schulenburg J.M.
(2019):
Patient-reported data informing early benefit assessment of rare diseases in Germany: A systematic review,
Health Economics Review, 9(1):34.
-
Babac A., von Friedrichs V., Litzkendorf S., Zeidler J., Damm K., Graf von der Schulenburg J.M.
(2019):
Integrating patient perspectives in medical decision-making: a qualitative interview study examining potentials within the rare disease information exchange process in practice,
BMC Medical Informatics and Decision Making, 19(1):188
-
de Jong L., Plöthner M., Stahmeyer J.T., Eberhard S., Zeidler J., Damm K.
(2019):
Informal and formal care preferences and expected willingness of providing elderly care in Germany: protocol for a mixed-methods study,
BMJ Open, 9(1)
-
Plöthner M., Schmidt K., de Jong L., Zeidler J., Damm K.
(2019):
Needs and preferences of informal caregivers regarding outpatient care for the elderly: a systematic literature review,
BMC Geriatrics, 19(1):82
-
Plöthner M., Schmidt K., Schips C., Damm K.
(2018):
Which attributes of whole genome sequencing tests are most important to the general population? Results from a German preference study,
Pharmacogenomics and Personalized Medicine, 11:7-21.
-
Aumann I., Litzkendorf S., Damm K., von der Schulenburg J.M.
(2017):
Priorisierung und Rationierung von Arzneimittel – eine experimentelle Analyse von Diskussionsprozessen [Priority setting and rationing of pharmaceuticals –an experimental analysis of discussion processes],
Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, 125:3-13.
-
Babac A., Litzkendorf S., Schmidt K., Pauer F., Damm K., Frank M., von der Schulenburg J.M.
(2017):
Shaping an Effective Health Information Website on Rare Diseases Using a Group Decision- Making Tool: Inclusion of the Perspectives of Patients, Their Family Members, and Physicians,
Interactive Journal of Medical Research, 6(2)
-
Schmidt K., Damm K., Vogel A., Golpon H., Manns M.P., Welte T., von der Schulenburg J.M.
(2017):
Therapy preferences of patients with lung and colon cancer: a discrete choice experiment,
Patient Preference and Adherence, 11:1647-1656.
-
Damm K., Volk J., Horn A., Allam J.P., Troensegaard-Petersen N., Serup-Hansen N., Winkler T., Thiessen I., Borchert K., Wüstenberg E.G., Mittendorf T.
(2016):
Patient preferences in allergy immunotherapy (AIT) in Germany - a discrete-choice-experiment,
Health Economics Review, 6(1):32.
-
Klose K., Kreimeier S., Tangermann U., Aumann I., Damm K., on behalf of the RHO Group
(2016):
Patient-and person-reports on healthcare: preferences, outcomes, experiences, and satisfaction -an essay,
Health Economics Review, 6(1):18.
-
Pauer F., Schmidt K., Babac A., Damm K., Frank M., von der Schulenburg J.M.
(2016):
Comparison of different approaches applied in Analytic Hierarchy Process –an example of information needs of patients with rare diseases,
BMC Medical Informatics and Decision Making, 16:117.
-
Schmidt K., Babac A., Pauer F., Damm K., von der Schulenburg J.M.
(2016):
Measuring patients' priorities using the Analytic Hierarchy Process in comparison with Best-Worst-Scaling and rating cards: methodological aspects and ranking tasks,
Health Economics Review, 6(1):50.
-
Aumann I., Kreis K., Damm K., Golpon H., Welte T., von der Schulenburg J.M.
(2015):
Treatment-related experiences and preferences of patients with lung cancer – a qualitative analysis,
Health Expectations; 19(6):1226-1236
-
Aumann I., Rozanski K., Damm K., von der Schulenburg J.M.
(2015):
Kosteneffektivität von pharmakologischen Raucherentwöhnungsmaßnahmen – ein systematisches Literaturreview [Cost-Effectiveness of Pharmacological Smoking Cessation Therapies –A Systematic Literature Review],
Das Gesundheitswesen; 78(10):660-671
-
Damm K., Prenzler A., Zuchandke A.
(2015):
Who prefers the “cost-effectiveness ratio” prioritization approach in health care decisions? Results of an empirical analysis,
Health Expectations; 18(6): 2413–2424
-
Schmidt K., Aumann I., Hollander I., Damm K., von der Schulenburg J.M.
(2015):
Applying the Analytic Hierarchy Process in healthcare research: A systematic literature review and evaluation of reporting,
BMC Medical Informatics and Decision Making, 15:112
-
Schmidt K., Damm K., Prenzler A., Golpon H., Welte T.
(2015):
Preferences of lung cancer patients for treatment and decision-making: A systematic literature review,
European Journal of Cancer Care;25(4):580-91
-
Damm K., Prenzler A., Zuchandke A.
(2014):
Does the perception of fairness and standard of care in the health system depend on the field of study? –Results of an empirical analysis,
BMC Health Services Research; 14:166.
-
Damm K., Vogel A., Prenzler A.
(2014):
Preferences of colorectal cancer patients for treatment and decision-making: a systematic literature review,
European Journal of Cancer Care; 23(6):762-72
-
Damm K., Jacob C., Mittendorf T., von der Schulenburg J.M.
(2012):
Lebensqualitätsmessung in klinischen Studien beim Lungenkarzinom – Übersicht anhand der Datenbank ClinicalTrials.gov.,
PharmacoEconomics - German Research Articles;10 (1):3-15
-
Damm K., Lange A., Zeidler J., Braun S., von der Schulenburg J.M.
(2012):
Einführung des neuen Tätigkeitsschlüssels und seine Anwendung in GKV-Routinedatenauswertungen –Möglichkeiten und Limitationen [Implementation of the new German job role code and its application in claims data analysis. Possibilities and limitations],
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 55(2):238
-
Damm K., Müller-Riemenschneider F., Vauth C., Willich S.N., Greiner W.
(2011):
Nichtmedikamentöse Sekundärprävention der koronaren Herzkrankheit –Gesundheitsökonomische Aspekte [Non-pharmacological secondary prevention of coronary heart disease],
Health economic aspects. Prävention und Gesundheitsförderung;6(4):255-261
-
Damm K., Runge C., Zeymer U., von der Schulenburg J.M.
(2011):
Krankheitskosten des akuten Koronarsyndroms in Deutschland [Cost of illness of acute coronary syndrome in Germany],
Der Kardiologe;5(2):122–128.
-
Damm K., Schubert M., von der Schulenburg J.M.
(2011):
Promoting vaccinations -an analysis of measures taken by German statutory health insurers,
Health Economics Review,1:16.
-
Enns T., Damm K., von der Schulenburg J.M.
(2011):
Freier Preiswettbewerb auf dem deutschen OTC-Markt -Das Verhalten von Apotheken und "Mass Market"[Free Pricing on the German Over-the-Counter Market - Behaviour of Pharmacies and Mass Market],
PhamacoEconomics - German Research Articles; 9(1):3-10
-
Müller-Riemenschneider F., Meinhard C., Damm K., Vauth C., Bockelbrink A., Greiner W., Willich S.N.
(2010):
Effectiveness of nonpharmacological secondary prevention of coronary heart disease,
European Journal of Cardiovascular Prevention and Rehabilitation; 17:688-700
-
Damm K., Scheunemann B., Vauth C., von der Schulenburg J.M.
(2009):
Fünf Jahre diagnosebezogene Fallpauschalen im stationären Sektor – Auswirkungen auf betriebsinterne Strukturen und Prozesse von Krankenhäusern [Five Years of Diagnosis Related Groups in the Inpatient Sector – Effects on In-House Structures and Processes of Hospitals],
Betriebswirtschaftliche Forschung und Praxis; 61 (3):271-282
-
Müller-Riemenschneider F., Damm K., Meinhard C., Bockelbrink A., Vauth C., Willich S.N., Greiner W.
(2009):
Evaluation of medical and health economic effectiveness of non-pharmacological secondary prevention of coronary heart disease,
GMS Health Technology Assessment; 5: Doc16
